Annapolis Junction, MD, July 17, 2017 -- Colfax Corporation (“Colfax”) (NYSE: CFX), a leading global manufacturer of gas- and fluid-handling and fabrication technology products and services, today announced that it will issue a press release providing financial results for the second quarter of 2017 on the morning of Friday, July 28, 2017. The Company will hold a conference call to discuss these results beginning at 9:00 a.m. Eastern on that day, which will be open to the public through 877-303-7908 (U.S. callers) and +1-678-373-0875 (international callers) and referencing the conference ID number 55207787 or through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.
Colfax’s financial results press release and supplemental financial information referenced on the call, if any, for the second quarter of 2017 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.
ABOUT COLFAX CORPORATION — Colfax Corporation is a diversified manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker "CFX." Additional information about Colfax is available at www.colfaxcorp.com.
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2016 Annual Report on Form 10-K under the caption "Risk Factors." In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of this date hereof. Colfax disclaims any duty to update the information herein.
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.
Investor Contact: Terry Ross, VP of Investor Relations Colfax Corporation (301) 323-9054 [email protected]


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 



